Molly Harper serves as Executive at CATALYST PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Molly Harper has executed 14 insider transactions totaling $910.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 29, 2025 involved exercising options for 1,334 shares valued at $0.
Molly Harper currently holds 3,694 shares of CATALYST PHARMACEUTICALS, INC. (CPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Molly Harper has been a net seller of CPRX stock. They have purchased $0 and sold $910.3K worth of shares.
Molly Harper's most recent insider trade was on Dec 29, 2025, when they sold 1,334 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $23.06 |
| Discretionary |
| Dec 12, 2025 | CPRX | $115.6K | Option Exercise | 20,000 | $5.78 | Discretionary |
| Dec 12, 2025 | CPRX | $360.2K | Sale | 15,527 | $23.20 | Discretionary |
| Dec 12, 2025 | CPRX | $106.1K | Sale | 4,473 | $23.73 | Discretionary |
| Dec 8, 2025 | CPRX | $0 | Option Exercise | 1,413 | $N/A | Discretionary |
| Nov 21, 2025 | CPRX | $0 | Option Exercise | 947 | $N/A | Discretionary |
| Jun 3, 2024 | CPRX | $86.9K | Sale | 5,333 | $16.30 | Discretionary |
| Feb 15, 2024 | CPRX | $0 | Option Exercise | 4,000 | $N/A | Discretionary |
| Dec 27, 2023 | CPRX | $0 | Option Exercise | 1,333 | $N/A | Discretionary |
| Dec 15, 2023 | CPRX | $57.8K | Option Exercise | 10,000 | $5.78 | Discretionary |
| Dec 15, 2023 | CPRX | $57.7K | Sale | 4,000 | $14.43 | Discretionary |
| Dec 15, 2023 | CPRX | $143.7K | Sale | 10,000 | $14.37 | Discretionary |
| Feb 15, 2023 | CPRX | $0 | Option Exercise | 4,000 | $N/A | Discretionary |